KFDA to promote ADR monitoring system

Published: 2003-05-19 06:57:00

Updated: 2003-05-19 06:57:00

The Korea Food and Drug Administration said recently that as part of offering most up-date drug-related safety information to medical professionals in a rapid and accurate manner, it will push up with an up-date drug reaction (ADR) monitoring plan through efficient establishment of a unified data...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK